AEGiS-Reuters: Suicide Bombers Can Threaten from Beyond the Grave

Reuters, Ltd.Important note: Information in this article was accurate in 2002. The state of the art may have changed since the publication date.
Click here to return to Reuters main menu






DonateNow


Suicide Bombers Can Threaten from Beyond the Grave

Reuters NewMedia - July 24, 2002


LONDON (Reuters) - Suicide bombers could be endangering the lives of people from beyond the grave by passing on hepatitis or blood-borne diseases to survivors, a science magazine reported on Wednesday.

Israeli doctors have found fragments of bone from a suicide bomber embedded in a 31-year-old woman who survived the attack. The fragments tested positive for liver disease hepatitis B.

Itzhak Braverman, of the Hillel Yaffe Medical Center in Hadera, Israel, told New Scientist magazine he believed it was the first report of human bone fragments acting as foreign bodies in a blast injury.

"No one had considered this danger before," New Scientist magazine said.

The magazine gave no details about when or where the suicide attack took place.

Braverman said he believed all embedded bone fragments in survivors of such bombings should be routinely tested for diseases such as hepatitis, dengue fever, syphilis, the human form of mad cow disease and possibly malaria. He also said survivors were being vaccinated.

"As a result of that case, all survivors of these attacks in Israel are now vaccinated from hepatitis B," Braverman told the magazine.

The biggest fear is finding HIV, which causes AIDS.

Braverman said the woman tested negative for HIV but added that the tests used are normally designed for blood and analysing bone fragments for diseases is more difficult.

At least 1,467 Palestinians and 559 Israelis have been killed since Palestinians began a revolt in September 2000 shortly after negotiations for a final peace treaty deadlocked.


020724
RE020762


Copyright © 2002 - Reuters, Ltd. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.   Contact Reuters.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 2002. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2002. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .